Logo

Ares Genetics ARESCloud

Oct 21, 2021

Ares Genetics, an OpGen subsidiary, has commercially launched ARESCloud, a web application aimed at accelerating the analysis of sequenced clinical isolates. The software fully auotmates data processing, from raw sequence data to report, and offers insights into epidemiologically and etiologically relevant information including pathogen identity, genotype, virulence, plasmids, and antimicrobial resistance. The news software also features tools for comparative and outbreak analysis. Under a simple subscription model users can access ARESdb, a proprietary knowledgebase containing comprehensive information on genetic and mutational AMR markers as well as advanced machine-learning models for the prediction of antibiograms directly from genomic data, the company said.

Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.